You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
次新異動 | Vesync午後漲超25%,榮昌生物-B、泡泡瑪特漲超11%

uSMART盈立智投12月21日消息,週一港股,次新股繼續遭市場熱炒,小家電商Vesync午後盤中漲超25%,未盈利生物醫藥公司榮昌生物-B、"盲盒第一股"泡泡瑪特均漲超11%,華潤萬象生活漲近7%。

在中概股及未有收入的生物科技股帶動下,今年港股IPO市場表現出色。

根據德勤的統計數據顯示,截至今年12月31日,香港市場預計會有145只新股上市集資約3973億港元,而2019年則有164只新股集資3155億港元。這意味着新股數量下跌12%,而新股集資額增加26%。

從掛牌首日的股價表現來看,今年港股市場所有新股的首日投資回報達到21%,相比去年同期的11%大幅上升。由於新股投資回報理想,吸引了大批散戶加入“打新”大戰。93%的IPO獲得超額認購,並有56%的IPO獲得超額認購20倍以上。

在新股定價方面,今年近一半的新股在港交所以發售價格區間中間值或以上上市,32%的新股以20倍或以上的市盈率上市,比去年的22%大幅上升;以40倍以上的市盈率上市的新股比重則從去年的9%升至17%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account